• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 POS filed by Tivity Health Inc.

    6/28/22 4:21:54 PM ET
    $TVTY
    Medical Specialities
    Health Care
    Get the next $TVTY alert in real time by email
    S-8 POS 1 tvty-s8pos.htm S-8 POS tvty-s8pos.htm

     

    As filed with the Securities and Exchange Commission on June 28, 2022

     

    Registration No. 333-231752

    Registration No. 333-230173

    Registration No. 333-204313

    Registration No. 333-197025

    Registration No. 333-167818

    Registration No. 333-140950

    Registration No. 333-122881

    Registration No. 333-113149

    Registration No. 333-103510

    Registration No. 333-70948

    Registration No. 333-33336

    Registration No. 333-04615

    UNITED STATES

    Securities and Exchange Commission

    Washington, D.C. 20549

     

    POST-EFFECTIVE AMENDMENT NO. 1 TO

    Form S-8 Registration No. 333-231752

    Form S-8 Registration No. 333-230173

    Form S-8 Registration No. 333-204313

    Form S-8 Registration No. 333-197025

    Form S-8 Registration No. 333-167818

    Form S-8 Registration No. 333-140950

    Form S-8 Registration No. 333-122881

    Form S-8 Registration No. 333-113149

    Form S-8 Registration No. 333-103510

    Form S-8 Registration No. 333-70948

    Form S-8 Registration No. 333-33336

    Form S-8 Registration No. 333-04615

    REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

     

     

    TIVITY HEALTH, INC.

    (Exact name of registrant as specified in its charter)

     

    Delaware

     

    62-1117144

    (State or other jurisdiction of

    incorporation or organization)

     

    (I.R.S. Employer Identification Number)

     

    701 Cool Springs Boulevard

    Franklin, Tennessee 37067

    (Address, including zip code, of principal executive offices)

     

     

     

     


     

     

    Tivity Health, Inc. Second Amended and Restated 2014 Stock Incentive Plan

    Nutrisystem Stock Incentive Plan

    Healthways, Inc. Amended and Restated 2014 Stock Incentive Plan

    Healthways, Inc. 2014 Stock Incentive Plan

    Healthways, Inc. 2007 Stock Incentive Plan

    American Healthways, Inc. 1996 Stock Incentive Plan

    American Healthways, Inc. 2001 Stock Option Plan for New Employees

    American Healthcorp, Inc. 1996 Stock Incentive Plan

    (Full title of the plan)

     

     

    J. Raymond Bilbao

    Chief Legal Officer & Corporate Secretary

    Tivity Health, Inc.

    701 Cool Springs Boulevard

    Franklin, Tennessee 37067

    Telephone: (800) 869-5311

    (Name, address and telephone number, including area code, of agent for service)

     

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer ☑

    Accelerated filer ☐

    Non-accelerated filer ☐

    Smaller reporting company ☐

    Emerging growth company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     


     

     

    DEREGISTRATION OF UNSOLD SECURITIES

     

    This Post-Effective Amendment (this “Post-Effective Amendment”) relates to the following Registration Statements (collectively, the “Registration Statements”) of Tivity Health, Inc. (the “Company”):

     

     

    •

    Registration Statement No. 333-231752, registering shares of the Company’s common stock, par value $0.001 per share (“Common Stock”), issuable pursuant to the Tivity Health, Inc. Second Amended and Restated 2014 Stock Incentive Plan, filed with the Securities and Exchange Commission (the “SEC”) on May 24, 2019;

     

     

    •

    Registration Statement No. 333-230173, registering shares of Common Stock, issuable pursuant to the Nutrisystem Stock Incentive Plan, filed with the SEC on March 8, 2019;

     

     

    •

    Registration Statement No. 333-204313, registering shares of Common Stock, issuable pursuant to the Healthways, Inc. Amended and Restated 2014 Stock Incentive Plan, filed with the SEC on May 19, 2015;

     

     

    •

    Registration Statement No. 333-197025, registering shares of Common Stock, issuable pursuant to the Healthways, Inc. 2014 Stock Incentive Plan, filed with the SEC on June 25, 2014;

     

     

    •

    Registration Statement No. 333-167818, registering shares of Common Stock, issuable pursuant to the Healthways, Inc. 2007 Stock Incentive Plan, filed with the SEC on June 25, 2010;

     

     

    •

    Registration Statement No. 333-140950, registering shares of Common Stock, issuable pursuant to the Healthways, Inc. 2007 Stock Incentive Plan, filed with the SEC on February 28, 2007;

     

     

    •

    Registration Statement No. 333-122881, registering shares of Common Stock, issuable pursuant to the American Healthways, Inc. 1996 Stock Incentive Plan, filed with the SEC on February 17, 2005;

     

     

    •

    Registration Statement No. 333-113149, registering shares of Common Stock, issuable pursuant to the American Healthways, Inc. 1996 Stock Incentive Plan, filed with the SEC on February 27, 2004;

     

     

    •

    Registration Statement No. 333-103510, registering shares of Common Stock, issuable pursuant to the American Healthways, Inc. 1996 Stock Incentive Plan, filed with the SEC on February 28, 2003;

     

     

    •

    Registration Statement No. 333-70948, registering shares of Common Stock, issuable pursuant to the American Healthways, Inc. 2001 Stock Option Plan for New Employees, filed with the SEC on October 4, 2001;

     

     

    •

    Registration Statement No. 333-33336, registering shares of Common Stock, issuable pursuant to the American Healthways, Inc. 1996 Stock Incentive Plan, filed with the SEC on March 27, 2000; and

     

     

    •

    Registration Statement No. 333-04615, registering shares of Common Stock, issuable pursuant to the American Healthcorp, Inc. 1996 Stock Incentive Plan, filed with the SEC on May 28, 1996.

     

    On April 5, 2022, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”), dated as of April 5, 2022, by and among the Company, Titan-Atlas Parent, Inc., presently known as Tivity Health OpCo Parent, Inc., a Delaware corporation (“Parent”), and Titan-Atlas Merger Sub, Inc., a Delaware corporation (“Merger Sub”), providing for the acquisition of the Company by affiliates of Stone Point Capital LLC (“Stone Point Capital”), subject to the terms and conditions set forth therein (the “Merger”).

     

    On June 28, 2022, the Merger became effective as a result of the filing of a Certificate of Merger with the Secretary of State of the State of Delaware (the “Effective Time”). As a result of the Merger, except as otherwise provided in the Merger Agreement, at the Effective Time, each share of Common Stock, issued and outstanding immediately prior to the Effective Time was converted into the right to receive $32.50 in cash, without interest (the “Transaction Consideration”). In addition:

     

     

    •

    each option to purchase Common Stock outstanding immediately prior to the Effective Time (each, an “Company Option”), whether vested or unvested, was cancelled and entitles the holder to receive an

     


     

     

    amount in cash (without interest and subject to applicable withholding taxes) equal to the product of (i) the number of shares of Common Stock subject to such Company Option as of immediately prior to the Effective Time and (ii) the excess, if any, of the Transaction Consideration over the exercise price per share of such Company Option. Any Company Options outstanding with an exercise price equal to or in excess of the per share Transaction Consideration was cancelled without any payment to the holder thereof;

     

     

    •

    each market stock unit award of the Company (each, a “Company MSU Award”) outstanding immediately prior to the Effective Time became vested, was cancelled and entitles the holder thereof to receive an amount in cash (without interest and subject to applicable withholding taxes) equal to the product of (i) the number of shares of Common Stock that would have vested pursuant to the terms of such Company MSU Award based on actual performance through the Effective Time, and (ii) the Transaction Consideration; and

     

     

    •

    each restricted stock unit award of the Company (each, a “Company RSU Award”) outstanding immediately prior to the Effective Time, subject to certain exceptions, became fully vested, was cancelled and entitles the holder to receive an amount in cash (without interest and subject to applicable withholding taxes) equal to the product of (i) the number of shares of Common Stock subject to the Company RSU Award and (ii) the Transaction Consideration.

     

    As a result of the consummation of the Transactions, the Company has terminated all offerings of its securities pursuant to its existing registration statements, including the Registration Statements. Effective upon filing hereof, the Company hereby removes from registration all shares of Common Stock registered under the Registration Statements that remain unsold as of the date of this Post-Effective Amendment.

     

     


     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Act of 1933, as amended (the “Securities Act”), the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Post-Effective Amendment to the Registration Statements described above to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Franklin, State of Tennessee, on June 28, 2022.

     

    TIVITY HEALTH, INC.

     

     

     

    By:

    /s/ J. Raymond Bilbao

     

     

    Name:

    J. Raymond Bilbao

     

     

    Title:

    Chief Legal Officer & Corporate Secretary

     

     

     

    No other person is required to sign this Post-Effective Amendment in reliance upon Rule 478 under the Securities Act.

     

     

    Get the next $TVTY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $TVTY

    DatePrice TargetRatingAnalyst
    4/1/2022$31.00Neutral
    Credit Suisse
    3/11/2022$29.00 → $31.00Neutral
    Credit Suisse
    1/7/2022$25.00 → $29.00Underperform → Neutral
    Credit Suisse
    11/9/2021$21.00 → $25.00Underperform
    Credit Suisse
    More analyst ratings